A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

Adam S. Epstein New CEO of AliMed, Inc.

What To Know

  • The company has also reinvested in product development and has a strong pipeline of new products now commercializing for use in both acute and post-acute care settings.
  • Epstein will oversee the company's general operations and its diversified portfolio of products sold to a majority of the country's leading healthcare providers.

Healthcare product manufacturer and distributor, AliMed, Inc. announced today the promotion of Adam S. Epstein, 51, to the position of Chief Executive Officer, effective immediately.

In his new role, Adam S. Epstein will oversee the company’s general operations and its diversified portfolio of products sold to a majority of the country’s leading healthcare providers.

In his prior role as Chief Commercial Officer, Epstein directed all customer-facing, demand generation and product development activities. Under his new leadership, AliMed will continue to build a robust portfolio of contracted positions with major, national GPO’s, IDN’s, and Distribution partners to drive sales growth. The company has also reinvested in product development and has a strong pipeline of new products now commercializing for use in both acute and post-acute care settings.

AliMed’s strong brand identity is synonymous with 50-years of innovative products and customizations developed to address a range of healthcare challenges. “Adam has done a great job strengthening our relationships with major customers and key sales partners,” said AliMed’s Chair of the Board and President, Alexandra Cherubini. “He is committed to remaining relevant to our key partners and inspiring customer loyalty to our brand. He is a tremendous leader and I’m confident he will guide our business to even greater success.”

Epstein has worked at AliMed since late 2019. Prior to that, he held senior roles at UFP Technologies (NASDAQ: UFPT) and Dielectrics, Inc. leading the development, commercialization, and sales of medical products and devices.

“I am excited about continuing to build the business with our talented and dedicated team of professionals,” Epstein said. “The important work AliMed does, enables caregivers to positively impact their patients’ lives. Our mission is helping people help people. We’re proud to be doing that on many fronts, through our broad product portfolio, signature service, and community engagement program, AliCares.” Epstein holds degrees from the University of Rochester and the Isenberg School of Management at UMASS.

AliMed Inc. headquartered in Dedham, MA and founded over 50 years ago by Barbara and Julian Cherubini, built its reputation on high-value, differentiated offerings and exceptional service. This specialty medical supplies manufacturer and distributor has on-site customization capabilities for both domestic and international care providers, dealers, and distributors. AliMed’s broad portfolio of healthcare products is designed to improve patient outcomes and experience, serving needs from “hospital to home”.

Other Executives In the News

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Executives on the Move

“Adding Michael to the Avation leadership team is our next step in launching Vivally,” said Jill Schiaparelli, founder and CEO of Avation Medical. “Patients have been crystal clear that they want a surgical-free, non-invasive treatment option for their OAB symptoms. Our focus now is to ensure that Vivally is easily accessible to the 46 million patients suffering from OAB in this country.”
Dennis has an extraordinary depth of knowledge and is highly respected in the obesity field; I could not imagine anyone more perfect to lead our company,” said Jeff Arnold, Chairman and a Director at Xeno Biosciences since 2017.
Peter Eckes offers more than a 30-year career in the agricultural industry, and provides a unique appreciation for what it takes to bring innovation to the modern agriculture marketplace at scale without losing sight of farmer and consumer needs.